KCTD12 and colorectal carcinoma: Although not currently understood, we will further investigate how KCTD12 modulates the ERK pathway, and we speculate that the GABAB signaling pathway may also be crucial for cell survival, tumorigenicity, and drug resistance in some cancers, including CRC, as previously shown in the literature29, 30, 31.